- PharmTalk – Emergency Room Pharmacy (pharmacy.arizona.edu)
PharmTalk is a special production from the University of Arizona, College of Pharmacy that features Keith and Kevin Boesen.
Yes, we know the doctors are usually the stars in the hospital emergency room. And the pharmacist with special training in emergency medicine makes a big contribution too!
- Brookshire Grocery brings FlavoRx to customers (drugstorenews.com)
Brookshire Grocery announced this week that it would be equipping its pharmacies with Fillmaster Plus dispensing technology…feature FlavoRx medication flavoring….using FillPure’s water purification system for all water used in antibiotics and powdered suspension,...The machines make pharmaceutical reconstitution and flavoring easy while reducing dispensing errors…
- Sarepta and BioMarin race for an FDA tag that could be worth $350M-plus (fiercebiotech.com)
Rivals Sarepta Therapeutics and BioMarin Pharmaceutical are in line to become the next recipients of an FDA coupon for a fast review, each potentially picking up a sellable asset...The two companies separately received the FDA's rare pediatric disease designation for their in-development treatments for Duchenne muscular dystrophy. And if they can win approval for the drugs next year--by no means guaranteed--each will receive a voucher that promises...a 6-month FDA review for any drug, truncating the standard 10-month process. Such vouchers can be sold to the highest bidder, and their market value has skyrocketed over the past year…
- Pharmacy Times Week in Review: August 21, 2015 (pharmacytimes.com)
Ashley Talamo, Publisher: Pharmacy Times...(PTNN) This weekly video program highlights the latest in pharmacy news, product news, and more. (video)
- Is ketamine the best hope for curing major depression? (bloomberg.com)
Food and Drug Administration hasn’t approved ketamine for the treatment of mood disorders, but… studies show that it can quickly alleviate severe depression. There’s no regulation to stop doctors like Brooks from administering ketamine for nonapproved uses—a practice known as "off-label" treatment—"For patients who are suicidal…they can get relief within an hour or two,"…
- Potential Medication Errors Involving Insulin (pharmacytimes.com)
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville discusses medication errors involving insulin. (video)
- Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1 (fiercepharma.com)
On the flip side, AstraZeneca, GSK and J&J stock prices contracted… The first half of the year has provided a good ride for Big Pharma and its investors with indices up in the U.S. and Europe. Even Japanese drugmakers avoided the side effects of China's stock market meltdown and saw values rise 23%. But, of course, averages come from the highs and the lows and some players have actually seen share price declines during this bull market.
- Walmart pledges $25M disaster relief commitment, will host preparedness events (drugstorenews.com)
As the 10th anniversary of Hurrican Katrina approaches, Walmart and the Walmart Foundation are making a commitment to disaster relief efforts… the two organizations would be donating $25 million over five years to worldwide disaster relief and recovery efforts… We will continue to help communities prepare for - and recover from - the unexpected…
- Hydrogels: Study shows use in ulcerative colitis and Army invests in wound healing research (fiercedrugdelivery.com)
A hydrogel is a polymeric material capable of holding large amounts of water in its 3-D structural network. Because it acts as the gel equivalent of a sponge, hydrogels are ideal for delivering different kinds of drugs and performing necessary functions. This week, hydrogels have shown to be useful in treating inflammatory bowel problems...
- Union posts email exchange with Merck CEO over plant dangers from job cuts (fiercepharmamanufacturing.com)
'Day of appreciation' becomes flashpoint over 'forced' double shifts..Merck & Co.'s plant in Pennsylvania has been impacted by the drugmaker's drastic job cuts in the last 5 years, losing hundreds of manufacturing jobs. Now, in an email exchange made public by one of the unions there, a labor official has lashed out at CEO Ken Frazier, saying workers are now forced to work 16-hours shifts,the fatigue…puts themselves and others in danger...